C4 Therapeutics, Inc.

CCCC

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001662579

SEC filings (opens in a new tab)

No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding C4 Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of CCCC: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	84	92	+8
Shares	34.5M	47.0M	+12.5M (+36.2%)
Value	$64.5M	$265.6M	+$201.1M (+311.8%)

New holders (30)

Institutions that held C4 Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CCCC in Q4 2023
Institution	Shares	Value	% of portfolio
Ra Capital Management, L.P.	4,878,000	$27.6M	0.43%
Commodore Capital LP	3,800,000	$21.5M	1.88%
Balyasny Asset Management LLC	1,704,269	$9.63M	0.03%
Marshall Wace, LLP	1,123,061	$6.35M	0.01%
Jane Street Group, LLC	198,671	$1.12M	0.00%
Schonfeld Strategic Advisors LLC	102,379	$578.4K	0.00%
Simplex Trading, LLC	95,020	$536.0K	0.02%
TD Asset Management Inc	94,400	$533.4K	0.00%
Susquehanna Portfolio Strategies, LLC	91,127	$514.9K	0.01%
Bank of Montreal	76,800	$463.1K	0.00%
Arete Wealth Advisors, LLC	72,100	$407.4K	0.03%
Bellevue Group AG	62,000	$350.3K	0.01%
683 Capital Management, LLC	55,602	$314.2K	0.03%
Squarepoint Ops LLC	46,025	$260.0K	0.00%
Royce & Associates LP	42,554	$240.4K	0.00%
Manufacturers Life Insurance Company, The	26,329	$148.8K	0.00%
Lighthouse Investment Partners, LLC	21,981	$124.2K	0.01%
Y-Intercept (Hong Kong) Ltd	18,823	$106.3K	0.01%
Mirabella Financial Services LLP	18,400	$104.0K	0.01%
Boothbay Fund Management, LLC	13,400	$75.7K	0.00%
Lazard Asset Management LLC	12,375	$69.0K	0.00%
Sherbrooke Park Advisers LLC	11,131	$62.9K	0.03%
Shay Capital LLC	10,000	$56.5K	0.02%
FNY Investment Advisers, LLC	8,800	$49.0K	0.05%
Headlands Technologies LLC	6,880	$38.9K	0.01%
Point72 Asia (Singapore) Pte. Ltd.	3,928	$22.2K	0.01%
Cutler Group LP	2,600	$14.0K	0.00%
Avion Wealth	331	$2.00K	0.00%
Fairfield, Bush & Co.	200	$1.13K	0.00%
Coston, McIsaac & Partners	19	$0	0.00%

Sold out (22)

Institutions that held C4 Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of CCCC in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Aquilo Capital Management, LLC	1,990,334	$3.70M
Nantahala Capital Management, LLC	1,000,000	$1.86M
Two Sigma Investments, LP	402,527	$748.7K
Nextech Invest AG	375,857	$699.1K
Russell Investments Group, Ltd.	95,822	$178.2K
Public Employees Retirement System of Ohio	71,163	$132.0K
Ameriprise Financial Inc	69,486	$129.2K
Verition Fund Management LLC	31,388	$58.4K
State of Wisconsin Investment Board	30,200	$56.2K
Pale Fire Capital SE	19,200	$35.7K
Susquehanna Fundamental Investments, LLC	17,572	$32.7K
Tudor Investment Corp Et Al	15,223	$28.3K
SG Americas Securities, LLC	11,921	$22.0K
Quantbot Technologies LP	5,796	$10.8K
Federated Hermes, Inc.	3,141	$5.84K
Northwestern Mutual Wealth Management Co	2,628	$4.89K
China Universal Asset Management Co., Ltd.	1,269	$2.36K
Advisor Group Holdings, Inc.	1,000	$1.86K
Nisa Investment Advisors, LLC	490	$911
EverSource Wealth Advisors, LLC	448	$833
Daiwa Securities Group Inc.	142	$0
CWM, LLC	110	$0